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Hyperinsulinemic euglycemic clamplementary roles in regulating the consumption, uptake, oxidation and storage of
nutrients. Chronic consumption of diets that contain a high proportion of calories from saturated fat induces
a progressive deterioration in function of both hormones. Certain rat lines and strains of mice are particularly
sensitive to the obesogenic and diabetogenic effects of high fat diets, and have been used extensively to study
the developmental progression of insulin and leptin resistance in relation to the increasing adiposity that is
characteristic of their response to these diets. Some aspects of the diminished efﬁcacy of each hormone are
secondary to increased adiposity but a consensus is emerging to support the view that direct effects of
dietary components or their metabolites, independent of the resulting obesity, play important roles in
development of insulin and leptin resistance. In this minireview, we will examine the implications of
crosstalk between leptin and insulin signaling during the development of diet-induced obesity, emphasizing
potential interactions between pathways that occur among target sites, and exploring how these interactions
may inﬂuence the progression of obesity and diabetes.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionAfter the original description of variable diabetogenic effects of
high fat diets among mouse strains by Surwit et al. [1,2], the fat-
sensitive C57BL/6J mouse emerged as a key model to study the
developmental pathology of the obese/diabetic syndrome that
develops after chronic consumption of high fat (HF) diets. Various
rat lines respond similarly, and studies contrasting rats or mice on LF
versus HF diets have illustrated the global and tissue-speciﬁc changes
that occur during the time frame when defects in leptin and insulin
sensitivity ﬁrst become apparent. However, the question of whether
the initial stages of insulin resistance (IR) are the product of a uniform
progression of IR across tissues or the result of a sequential but
punctuated progression of IR among tissues remains open. HF diets
also increase circulating leptin levels and promote the development of
leptin resistance. Potential mechanisms of diet-induced leptin
resistance include decreased access of leptin to hypothalamic targets,
diminished responsiveness of hypothalamic neurons to leptin,
modiﬁed translation of leptin-dependent signals in downstream
target tissues, or some combination thereof [3]. The complex
progression of events involved in the development of insulin and
leptin resistance represents a signiﬁcant impediment to understand-
ing the underlying cause and effect mechanisms within each pathway.1 225 763 0274.
ys).
ll rights reserved.Given the overlap within the respective signaling pathways of each
hormone, crosstalk between the pathways is likely to become
signiﬁcant and contribute to the progression of diet-induced obesity
and diabetes.
2. Developmental progression of insulin and leptin resistance
during diet-induced obesity
The strong relationship between obesity and diabetes is well
documented but the underlying mechanisms which link develop-
ment of obesity to initiation and progression of insulin and leptin
resistance are less well understood. This is in part due to the chronic
nature of both conditions and the associated progressive deteriora-
tion in function of multiple, highly integrated organ systems which
function in concert to maintain glucose and energy homeostasis.
Because of the temporal nature of the process, it has been difﬁcult to
identify the tissue sites and events which constitute the initial steps
of IR and link deterioration in insulin sensitivity to progression of
diet-induced obesity and diabetes. For example, without careful
design, it is difﬁcult to establish that observed changes in tissue
responses and function are not secondary to the initial events which
alter insulin sensitivity, and thus a consequence rather than an
underlying cause of IR.
The original experiments of Surwit et al. [1,2] involved weaning
male C57BL/6J mice onto a diet high in saturated fat (58 kcal%)
derived primarily from coconut oil, and the mice developed fasting
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Variations of this initial design have used different amounts (58 vs
45 kcal%) and sources of fat (lard or palm oil vs coconut oil) in the
diet, as well as age when the diet was ﬁrst introduced. The modiﬁed
designs have also been used with various rat lines, and, in general,
the responses have been similar in the sense that the animals
increased fat deposition and developed some degree of IR, depend-
ing on length of time on the diet. Relatively few of the many studies
in rats and mice have used longitudinal approaches coupled with in
vivo measurements (hyperinsulinemic-euglycemic clamps) to eval-
uate whole body insulin sensitivity and identify the tissue sites
where IR ﬁrst appears. However, the consensus emerging from
limited studies with young animals is that the very high fat (55-
60 kcal%) diets produce a rapid deterioration (3 wks) in whole body
insulin sensitivity that coincides with a simultaneous reduction in
insulin-dependent glucose uptake in peripheral tissues coupledwith a
failure of insulin to suppress hepatic glucose production [4–6]. The
response pattern is common to both rats andmice on the very high fat
diet formulation (55-60 kcal%) and supports the view that whole body
IR is the product of a rapid, uniform progression of IR among
peripheral tissues [4–7]. In contrast, a different outcome is obtained
when rats or mice are given HF diets with a lower proportion of
calories from fat (i.e. 45 kcal% versus 55-60 kcal%). Consuming the
45 kcal% HF diet for 1-5 wks resulted in loss of suppression of hepatic
glucose production by insulin without any change in insulin-sensitive
glucose uptake in peripheral tissue [8,9]. These ﬁndings argue that loss
of insulin sensitivity in liver is responsible for the initial deterioration
in whole body insulin sensitivity. Mice on the 45 kcal% HF diet for
longer periods (12-14 wks) develop IR in peripheral tissues [10], but
this outcome may be a reﬂection of longer term consumption of the
45 kcal% HF diet and indicative of later stages in the progression. It
seems likely that the reported differences among studies are due to a
combination of differences in amount, source, and saturation of
dietary fat, as well as length of exposure and age of animals when the
test diets were ﬁrst introduced.
Leptin is a key component of the neuroendocrine circuitry that
regulates food intake and energy utilization, and its absence in ob/ob
mice produces a complex metabolic syndrome characterized by
hyperphagia and lowered rates of energy expenditure [11–13].
However, diet-induced obesity is not associated with an absence of
leptin, as circulating leptin is actually increased in proportion to the
increase in body adiposity. The failure of this hyperleptinemia to
produce any compensatory decrease in food intake or body weight
was initially viewed as evidence of leptin resistance. The existence of
high fat diet-induced leptin resistance has since been directly
demonstrated as a failure of exogenous leptin to suppress food intake
or induce weight loss [14–16]. Chronic consumption of HF diets
promotes the development of leptin resistance as deﬁned by both
criteria, but understanding the temporal sequence of events involved
in the development of diet-induced leptin resistance is complicated by
the anatomical and functional complexity of the leptin sensing,
signaling, and effector systems. Leptin functions to maintain body
weight homeostasis by modulating appetite control centers in the
hypothalamus and energy utilization in part by increasing sympa-
thetic outﬂow to peripheral tissues [17–20]. Sympathetic outﬂow to
adipose tissue enhances fat oxidation by coordinated transcriptional
activation of genes favoring substrate oxidation [21,22]. Thus in the
broadest sense, leptin acts to regulate adipose tissue reserves through
a coordinated suppression of energy intake and stimulation of fat
oxidation. The consensus is that leptin initiates these signals by
crossing the blood brain barrier and binding to receptors on
hypothalamic NPY/AGRP and POMC neurons, which activate STAT-3
through a Jak2-dependent pathway [23–26]. Leptin receptors are
expressed on neurons located primarily but not exclusively within the
arcuate nuclei, but emerging evidence suggests that proper integra-
tion of the complex behavioral and metabolic responses to leptinrequires input from these additional populations of leptin responsive
neurons [3,27].
Studies examining leptin sensitivity have typically measured the
ability of exogenous leptin, given either peripherally or centrally, to
activate hypothalamic STAT-3, reduce food intake, reduce body
weight, or increase sympathetic nervous system (SNS) activity. In
C57BL/6J mice weaned onto a 45 kcal% HF diet, Van Heek et al. [28]
reported that the anorectic response to leptinwas lost after 16 d on the
HF diet. Using essentially the same experimental design, El Haschimi
et al. [29] found that the 45 kcal% HF diet did not alter the ability of
peripherally injected leptin to activate hypothalamic STAT3. In
contrast, C57BL/6J mice weaned onto a higher percentage of dietary
fat (58 kcal% vs 45 kcal%) became fully resistant to both the anorectic
andmetabolic effects of peripherally injected leptin after 4 wks on the
diet [30]. However, the responses to leptin were not compromised
when it was administered centrally [30], suggesting compromised
access to hypothalamic target neurons as a basis for resistance to
peripherally injected leptin [31,32]. Although working with a different
strain of mice (AKR/J), Van Heek et al. [28] proposed a similar
mechanism to explain resistance to peripheral leptin after 8 wks on a
HF diet. Returning to the C57BL/6J model, longer term consumption
(15 wks) of the 45 kcal% HF diet fully compromised the ability of
peripherally injected leptin to activate STAT3, but also reduced the
capacity of hypothalamic neurons to respond to centrally injected
leptin [29]. The diminished response to central leptin argues that the
HF diet produced a second defect compromising cellular signaling at
some point upstream of STAT3 [29].
An important component of leptin's metabolic effects is mediated
through SNS stimulation of fat oxidation in adipose tissue [21,22].
Therefore, the observed decrease in β-adrenergic receptor function in
adipose tissue after long term (16wks) consumption of the 58 kcal%HF
diet [33] could diminish efﬁcacy of SNS input and limit translation of
this component of leptin's actions. However, in recent studies with
C57BL/6Jmice consuming the 58 kcal%HF diet for 8wks [30], centrally
administered leptin activated hypothalamic STAT3, reduced food
consumption, and increased UCP1 mRNA in BAT. The latter response
indicates that leptin signaling to brown adipose tissue was intact, but
in the same mice leptin was unable to increase UCP1 expression in
retroperitonealWAT but was able to decrease leptinmRNA. Given that
bothWAT responses are mediated by SNS input [17,34], the intactness
of the latter response indicates that SNS-dependent β-adrenergic
activation was not compromised in retroperitoneal WAT. Additional
studies showed that the diet-induced defect in UCP1 induction by
leptin was downstream of β-adrenergic receptor activation in retro-
peritonealWAT [30]. Together, these studies illustrate howHFdiets can
induce leptin resistance in part by compromising the ability of
peripheral target tissues to translate input from central effector
systems (SNS) that are regulated by hypothalamic leptin signaling.
Lastly, recent work has shown that the time course of leptin
signaling after peripheral injection of leptin is not synchronizedwithin
all regions of hypothalamic neurons expressing leptin receptors,
whereas centrally administered leptin produces simultaneous leptin-
dependent signaling among these neuronal populations [27,35,36].
This ﬁnding argues that peripherally injected leptin does not reach all
leptin responsive neurons at the same time, and it suggests that a
population of ARC neurons expressing leptin receptors may extend
processes across the BBB to directly contact the circulation [27]. These
ﬁndings also raise the interesting possibility that this population of
leptin responsive neurons may be more subject to desensitization by
high leptin levels or other circulating factors associated with chronic
consumption of HF diets [32].
3. Mechanisms of diet-induced insulin resistance
A growing consensus supports the view that accumulation of lipid
in tissues not designed for storage is a key initial step in the
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characterized by defective storage of triglyceride in adipose tissue, and
the resulting oversupply of lipids to metabolic organs produces
ectopic fat accumulation and the development of IR [39]. Chronic
consumption of HF diets results in a similar oversupply of lipids to
metabolic organs that is temporally related to periods of rapid weight
gain, and associated with decreased insulin sensitivity and impaired
glucose homeostasis [38,40]. Muoio et al. [41,42] have presented
evidence that the oversupply of lipids to mitochondria produces a
mismatch between TCA cycle ﬂux and fat oxidation that results in
depletion of organic acid intermediates, incomplete fatty acid
oxidation, and accumulation of lipotoxic short chain fatty acylcarni-
tines. Although the underlying mechanisms remain unclear, the
accumulation of these lipotoxic metabolites compromises insulin
signaling and is associated with the onset of IR in skeletal muscle of HF
fed Wistar rats. A reversal of the mismatched metabolic ﬂux could be
obtained by increasing mitochondrial oxidative capacity or limiting
entry of fatty acids into mitochondria [41–43], both of which restored
complete fatty acid oxidation and insulin sensitivity. It remains to be
seen whether a similar mechanism is involved in compromising
insulin sensitivity in other peripheral tissues such as the liver, where
IR ﬁrst appears with the 45 kcal% HF diet.
4. Cellular mechanisms of diet-induced leptin resistance
While the existence of leptin resistance is widely accepted, the
physiological and cellular mechanisms that underlie this state are less
clear. This is due in part to the complexity of the system itself,
and the fact that leptin resistance could occur at multiple points
within this multifaceted cascade. It has been argued that high fat diets
lead to reduced leptin transport across the blood brain barrier (BBB)
[31], consistent with work demonstrating reduced sensitivity to
peripherally administered leptin prior to loss of central leptin
sensitivity [28,30]. Nevertheless, the cellular mechanisms of leptin
transport and its disruption in obesity are not fully resolved
[31,32,44,45], and some neurons within the hypothalamic arcuate
nucleus may extend projections beyond the BBB to directly sample
hormones in circulation [27]. It has also been established that HF diets
compromise leptin signaling within target neurons [29,46–48]. This
resistance is manifest as a loss of leptin-dependent suppression of
food intake and impaired activation of speciﬁc signaling pathways,
namely Stat3 and PI3K [3,47]. Leptin resistance could also occur
indirectly, with loss of sensitivity in various effector pathways
mediating downstream effects of the leptin receptor. For instance,
some have detected a HF-induced loss of sensitivity to melanocortins,
although others fail to detect this resistance [49–52]. Lastly, there is
evidence for selective leptin resistance based on physiological
endpoint, a loss of leptin-dependent suppression of food intake
despite a maintenance of leptin-dependent stimulation of sympa-
thetic outﬂow to peripheral tissues [30,53,54]. In summary, these
examples illustrate the challenges that are inherent to understanding
the origins and mechanisms of leptin resistance.
In assessing potential causes of leptin resistance, perhaps the most
progress has been made in deﬁning molecular mediators of cellular
leptin resistance. This work has identiﬁed two molecules which
inhibit leptin receptor signaling; suppressor of cytokine signaling 3
(Socs3) and protein tyrosine phosphatase 1B (PTP1B). Socs3 is one of
a family of proteins produced in response to cytokine signaling which
functions as an intracellular negative feedback signal [55]. Socs3
expression is induced by Stat3 signaling and it blocks Stat3 activation
by binding to the leptin receptor [56,57]. Mice bearing genetic
modiﬁcations which delete Socs3 or inhibit its ability to bind the
leptin receptor exhibit reduced food intake and body weight and are
resistant to diet-induced obesity [58–60].
Protein tyrosine phosphatase 1B (PTP1B) is similarly implicated in
leptin resistance due to its ability to limit the magnitude and durationof leptin receptor signaling. PTP1B binds to and dephosphorylates
Janus Kinase 2 (Jak2), the initial tyrosine kinase activated by the
leptin receptor [61,62]. Overexpression of PTP1B in vitro dampens
signaling from the leptin receptor [63], and mice genetically deﬁcient
for PTP1B are lean and hypersensitive to leptin [61,62]. Neuron-
speciﬁc deletion of PTP1B recapitulates the leptin hypersensitivity
and resistance to diet-induced obesity [64], and local inhibition of
PTP1B via pharmacological or adenoviral approaches enhances the
effects of central leptin injection [65,66]. Thus, these data indicate
that PTP1B, like Socs3, tonically inhibits signaling from the leptin
receptor.
Interestingly, Socs3 and PTP1B are also associated with regulation
of insulin signaling. PTP1B limits insulin signaling by binding to and
dephosphorylating the insulin receptor, and mice with global PTP1B
deﬁciency are hypersensitive to insulin [67]. Similarly, Socs3 inhibits
insulin receptor signaling in vitro and in vivo [68,69]. Given that leptin
and insulin regulate a common set of hypothalamic neurons, the
overlapping function of these two inhibitors has the potential to
produce signiﬁcant crosstalk between the signaling pathways,
particularly during diet-induced obesity as hyperinsulinemia and
hyperleptinemia develop [70]. Thus PTP1B and/or Socs3 could
underlie the combined loss of sensitivity to leptin and insulin that
are observed in obesity.
5. Direct and indirect effects of high fat diets on leptin signaling
Available evidence suggests that high fat diets induce leptin
resistance via both direct and indirect mechanisms. Direct
mechanisms refer to the ability of high fat diets to induce leptin
resistance in the absence of obesity, presumably via direct effects of
its components or metabolites on leptin-sensitive neurons. In
contrast, indirect mechanisms reﬂect an induction of leptin
resistance that is secondary to obesity and the associated
hyperleptinemia and are thus not dependent on the presence of
excess dietary fat.
Several lines of evidence indicate that HF diets can induce
hypothalamic leptin (and insulin) resistance in the absence of either
obesity or elevated circulating leptin. For example, recent work
detected diet-induced leptin and insulin resistance prior to any
change in body adiposity [71], while others have detected central
insulin resistance in HF-fed animals, even when obesity is prevented
via caloric restriction [72]. Obesity prone rat lines exhibit reduced
central leptin and insulin sensitivity prior to becoming obese on HF
diets [73–75], suggesting that some degree of basal resistance
contributes to their propensity to become obese. We recently
examined leptin signaling in ob/ob mice to determine whether HF
diets could modify leptin sensitivity in the absence of leptin.
Notwithstanding the high initial sensitivity of ob/ob mice to
exogenous leptin (see below), consumption of the HF diet for
14 d attenuated leptin's anorectic effects, indicating that leptin
resistance can be induced in the absence of leptin and hyperlepti-
nemia [76]. Lastly, these ﬁndings are also consistent with evidence
that hypothalamic neurons are sensitive to and respond directly to
fatty acids and other lipid metabolites ([77,78] and see section
below).
In addition to direct effects of dietary fat that deamplify leptin
signaling, the evidence supports indirect mechanisms that are
secondary to development of obesity and chronic hyperleptinemia.
In practice, nearly all settings of leptin resistance are associated
with chronic elevation of circulating leptin, and it appears that chronic
hyperleptinemia inhibits leptin sensitivity via down regulation of
leptin receptors and stimulation of negative feedback molecules
such as Socs3 and PTP1B [56,68,79]. Additional evidence supporting
a role for hyperleptinemia stems from genetic models. Despite
their massive obesity, leptin-deﬁcient ob/obmice are highly sensitive
to leptin [80]. Similarly, the leptin resistance of agouti viable yellow
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Ay mutation onto the ob/ob background [81]. Together these
observations suggest that a component of the leptin resistance of Ay
mice is induced by hyperleptinemia. Chronic infusion of exogenous
leptin induces a form of leptin-induced leptin resistance [48,82], and
predisposes animals to increased weight gain on a HF diet [83,84].
Together, these ﬁndings argue that this leptin-induced leptin
resistance alters the regulation of energy homeostasis and increases
the risk for obesity.
Viewed collectively, these ﬁndings indicate that leptin resistance
is both a cause and a consequence of obesity [85]. Loss of leptin
signaling clearly predisposes to weight gain, while interventions
which enhance leptin signaling protect against diet-induced obesity.
These observations, coupled with evidence for HF-induced, obesity
independent reductions in leptin sensitivity, support a causative role
for leptin resistance in the development of obesity. However, a
consequence of the expanding adipose mass of obesity is a chronicFig. 1. Interactions between insulin and leptin signaling in mice reared on low fat diets (Pane
after chronic consumption (4-5mo after weaning) of high fat diet (Panel C). Animals placed o
shuts down hepatic glucose production, via both direct and indirect pathways, and promot
adipose tissue suppresses food intake and stimulates the sympathetic tonus, which ensures
short period of time (Panel B) display hepatic insulin resistance, despite preserved insulin sen
caused by the direct actions of high fat availability on gluconeogenesis or the hypothalamu
pathway. This period of selective hepatic insulin resistance is characterized by increased c
When these mice are kept on a high fat diet for a longer period of time (Panel C), hepatic insu
sensitivity, but the exacerbated fat accumulation in adipose tissue and subsequent hyperlepti
hyperinsulinemia and chronic high fat availability have also been shown to promote a condi
fatty acids occur in peripheral tissues, ultimately leading to a complete loss of their insulinincrease in circulating leptin, which acts on the hypothalamus to
further dampen leptin signaling.
6. Direct effects of fatty acids on hypothalamic neurons
In addition to their endocrine sensing and response systems,
hypothalamic neurons also possess a nutrient sensing system that is
sensitive to circulating lipids and provides regulatory inputs into
systemic glucose homeostasis. Increasing hypothalamic long chain
fatty acids (LCFA-CoA) via either direct ICV administration of oleic
acid [86] or inhibition of hypothalamic carnitine palmitoyltransfer-
ase-1 (CPT-1) [87,88] causes a marked decrease in hepatic glucose
production via suppression of glycogenolysis. This hypothalamic lipid
sensing mechanism appears to require the opening of hypothalamic
KATP channels and an intact vagus [77]. While LCFAs suppress hepatic
glucose output via the hypothalamus, they increase hepatic glucose
production through a direct effect on the liver [89]. Thus, thisl A), mice reared for 4-8 wks after weaning on 45 kcal% high fat diet (Panel B), and mice
n a low fat diet (Panel A) exhibit normal systemic insulin sensitivity. After ameal, insulin
es glucose uptake in muscle and adipose tissue. The subsequent release of leptin from
lipid mobilization and fatty acid oxidation during fasting. Mice fed a high fat diet for a
sitivity in muscle and adipose tissue. The loss of hepatic insulin sensitivity is most likely
s, which would suppress hepatic glucose output under normal conditions via a vagal
irculating glucose levels, hyperinsulinemia and a signiﬁcant increase in fat deposition.
lin resistance becomes more severe. Initially the peripheral tissues still maintain insulin
nemia cause hypothalamic leptin resistance via the induction of SOCS3 and PTP1B. Basal
tion in which incomplete fatty acid oxidation and accumulation of lipotoxic short chain
sensitivity.
Fig. 1 (continued).
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centrally mediated inhibitory effects of LCFA. In addition to LCFAs,
there is also evidence that triglycerides may act in the brain to reduce
leptin transport across the blood brain barrier [32]. Lastly, given the
substantial overlap between leptin and insulin signaling and the
emerging consensus that dysregulation of lipid metabolism is at the
core of peripheral insulin resistance, it appears likely that similar
mechanisms occur in the brain and could contribute to central leptin
resistance. Taken together, these data indicate that fatty acids,
triglycerides and lipid molecules act locally in the brain to inﬂuence
leptin transport, food intake and peripheral glucose metabolism, and
as such provide additional mechanisms through which the chronic
consumption of a HF diet might be compromising body weight and
glucose homeostasis.
7. Implications of crosstalk between leptin and insulin during
development of diet-induced obesity
Postweaning consumption of diets rich in saturated fatty acids
results in the progressive development of insulin resistance, leptin
resistance, and obesity in C57BL/6J mice. Maintenance of glucose and
energy homeostasis requires the proper integration of complex
communication and effector systems, and the collective evidence
shows that chronic consumption of HF diets progressively compro-mises the function of essential components and steps within these
systems. The difﬁculty in understanding the underlying sequence of
events in this overall process is underscored by the fact that the
progression is also dependent on the source and amount of fat in the
diet. Therefore, the following comments are an attempt to summarize
the key early responses of C57BL/6J mice to HF diets, suggesting
potential points of interaction between insulin and leptin signaling
that may contribute to or accentuate the progressive dysregulation of
glucose and energy homeostasis.
Consumption of the very high fat (58 kcal%) diet formulation for
2-3 wks after weaning produces a rapid, uniform increase in IR among
peripheral tissues [4,5]. The IR, detected by hyperinsulinemic-
euglycemic clamps, is a reﬂection of both compromised insulin-
dependent glucose uptake in peripheral tissues and compromised
insulin-dependent suppression of hepatic glucose production [4].
After 2 wks on the 58 kcal% HF diet, C57BL/6J mice are signiﬁcantly
fatter than LF-fed mice [90] and by 4 wks are completely resistant to
peripherally injected leptin [30,35]. Mice on the 58 kcal% HF diet
retain sensitivity to centrally administered leptin at this time point,
increasing hypothalamic STAT3 phosphorylation, reducing food intake
and increasing UCP1 expression in BAT after ICV injection of leptin
[30]. Together these data indicate that the 58 kcal% HF formulation
produces a rapid and almost simultaneous increase in adiposity and
deterioration of signaling through insulin and leptin. Moreover, it
appears that beyond the 4 wk time point, it becomes difﬁcult to argue
that observed changes are not secondary to signaling defects
developed earlier in the progression.
The progression of both IR and leptin resistance is signiﬁcantly
slower with the 45 kcal% versus the 58 kcal% HF diet. After 4 wks on
the lard-based 45 kcal% formulation, activation of hypothalamic STAT3
by peripheral leptin was not diminished in C57BL/6J mice [29], and it
was only after 15 wks on the HF diet that resistance to leptin was
observed. Using the 45 kcal% HF diet, recent studies have shown that
ambient temperature and rearing conditions also affect the progres-
sion of diet-induced leptin resistance [91–93]. However, it should be
noted that Munzberg et al. [35] have proposed that leptin resistance
may develop in a region-speciﬁc manner within the hypothalamus of
diet-induced obese mice, with resistance developing initially within
the arcuate nuclei. If different hypothalamic regions regulate different
components of the leptin response, it could explain how the
development of selective leptin resistance among subgroups of
responsive nuclei could eliminate certain components of leptin's
actions while others are preserved [53].
IR develops sooner (1-3 wks) than leptin resistance in both rats
[8,9] and C57BL/6J mice [94] consuming the 45 kcal% HF diet. Using
hyperinsulinemic-euglycemic clamps to measure in vivo insulin
sensitivity, a modest decrease in glucose utilization is detected in
C57BL/6J mice after 3 wks on the HF diet. This decrease in insulin
sensitivity can be fully accounted for by failure of insulin to suppress
hepatic glucose production, with no decrease in sensitivity of
peripheral tissues to insulin. Hepatic IR becomes somewhat more
severe between 3 and 8 wks on the 45 kcal% HF diet, but peripheral
tissues retain full responsiveness to insulin during this period [94].
It is noteworthy that the increase in hepatic IR between 3 and 8 wks
is sufﬁcient to increase pancreatic insulin release such that fasting
insulin levels are ∼2 fold higher than levels in control mice on a LF
diet. The establishment of hyperinsulinemia during a period when
peripheral tissues retain full insulin sensitivity has important
physiological implications. In addition to promoting glucose uptake
in peripheral tissues, insulin also activates phosphodiesterase 3B
[95–97], resulting in the degradation of cyclic AMP and the
antagonism of glucagon signaling in the liver. If the liver was
responsive to insulin during this period, the increase in insulin
would have the corrective effect of suppressing hepatic glucose
production. The hyperinsulinemia also could have important effects
in adipose tissue, where the lipogenic and antilipolytic effects of
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that the time frame (3 to 8 wks) when hyperinsulinemia develops
coincides with a signiﬁcant increase in the rate of fat deposition.
This may be a mechanism to compensate for the oversupply of
lipids provided by the 45 kcal% HF diet, and effectively slow the
progression of IR to peripheral tissues by preventing or delaying
ectopic fat accumulation. If correct, this suggests that there may be
a threshold of dietary fat that determines whether the early stage of
IR is limited to the liver or extends to other peripheral tissues.
The development of hyperinsulinemia between 3 to 8 wks may
also have important effects on the endocrine function of adipose
tissue. For example, previous studies have shown that insulin
increases the release of leptin from adipose tissue [98] while cyclic
AMP inhibits both leptin expression and release [17,98]. In addition to
promoting triglyceride accumulation, the higher insulin levels would
favor increased leptin expression and release from adipose tissue
during this period. Although beyond the scope of this minireview, it is
also likely that other components of the adipocyte endocrine
repertoire that are regulated by insulin and cyclic AMP would be
similarly affected.
Lastly, leptin regulates SNS outﬂow to adipose tissue, which acts
through cyclic AMP to mobilize triglyceride and transcriptionally
remodel adipose tissue. However, the increased serum insulin
levels would antagonize cyclic AMP-dependent signaling, effectively
limiting the efﬁcacy of leptin-dependent SNS input. Viewed
collectively, the promotion of hepatic IR of sufﬁcient magnitude
to increase circulating insulin, but not induce IR in peripheral
tissues, may be a critical characteristic of the response to the
45 kcal% version of the HF diet which promotes rapid fat
deposition and the subsequent development of leptin resistance.
It seems clear that detailed longitudinal studies at much earlier
time points will be required to resolve how and where the
signaling defects develop, where they interact, and how they
impact the expansion of adipose tissue mass.
8. Conclusions
It is well accepted that postweaning consumption of diets high in
saturated fat produces obesity and metabolic dysfunction. The
severity and developmental progression of this syndrome is depen-
dent upon the amount of dietary fat (45-60 kcal%), the strain of mouse
being studied, and the age at which exposure to the diet is initiated.
Our theoretical model (Fig. 1) is based on postweaning consumption
of a 45 kcal% high fat diet by C57BL/6J mice, and proposes that the
development of insulin resistance is progressive and tissue speciﬁc,
with high fat diets leading to hepatic insulin resistance prior to
detectable changes in insulin sensitivity in peripheral tissues. The
resulting increase in circulating insulin, in conjunction with retention
of peripheral insulin sensitivity, produces an expansion of adipose
mass and a concomitant increase in circulating leptin. This increase in
leptin, though perhaps initially acting to limit body adiposity, leads to
hypothalamic leptin resistance and a further dysregulation of energy
balance and glucose homeostasis. With continued exposure to a high
fat diet, the liver becomes progressively less responsive to insulin,
vagal inhibition of hepatic glucose production is diminished, and the
resulting oversupply of lipids to mitochondria of peripheral tissues
produces a mismatch between TCA cycle ﬂux and fat oxidation (Fig. 1,
Panel C). The result is incomplete fatty acid oxidation, accumulation of
lipotoxic short chain fatty acylcarnitines, and peripheral insulin
resistance. Adipose tissue in particular becomes resistant to inhibition
of leptin release by SNS input, resulting in chronic hyperleptinemia
and leptin resistance. Lastly, we recognize the possibility that excess
dietary fat may also directly induce hypothalamic leptin (and insulin)
resistance, with this effect serving to exacerbate the initial deteriora-
tion of peripheral insulin sensitivity and whole body energy
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